Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
Animal assisted interventions in neurorehabilitation: A review of the most recent literature.
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
Simvastatin regulates oligodendroglial process dynamics and survival.
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
B-50Alternate Scoring of the Paced Auditory Serial Addition Test (PASAT): Evaluating Strings of Consecutive Correct Responses as Predictors of Cognitive Functioning in Patients with Multiple Sclerosis.
Surveillance and medical therapy following endovascular treatment of chronic cerebrospinal venous insufficiency.
A Randomized Controlled Trial of Cognitive Behavioral Therapy (CBT) for Adjusting to Multiple Sclerosis (the saMS Trial): Does CBT Work and for Whom Does It Work?
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Peripheral neuropathy associated with mitochondrial disease in children.
A CB(1)/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.
Pitfalls of 3D FLAIR Brain Imaging: A Prospective Comparison with 2D FLAIR.
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.]
Tysabri screening test may be unreliable
Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes.
Physical fitness assessment in multiple sclerosis patients: A controlled study.

Pages